Abstract

Cerebral blood flow (CBF) is rigorously regulated by various powerful mechanisms to safeguard the match between cerebral metabolic demand and supply. The question of how a change in cardiac output (CO) affects CBF is fundamental, because CBF is dependent on constantly receiving a significant proportion of CO. The authors reviewed the studies that investigated the association between CO and CBF in healthy volunteers and patients with chronic heart failure. The overall evidence shows that an alteration in CO, either acutely or chronically, leads to a change in CBF that is independent of other CBF-regulating parameters including blood pressure and carbon dioxide. However, studies on the association between CO and CBF in patients with varying neurologic, medical, and surgical conditions were confounded by methodologic limitations. Given that CBF regulation is multifactorial but the various processes must exert their effects on the cerebral circulation simultaneously, the authors propose a conceptual framework that integrates the various CBF-regulating processes at the level of cerebral arteries/arterioles while still maintaining autoregulation. The clinical implications pertinent to the effect of CO on CBF are discussed. Outcome research relating to the management of CO and CBF in high-risk patients or during high-risk surgeries is needed.

Abstract

Cardiac output causally affects cerebral blood flow. A conceptualization is proposed for the purpose of integrating at the level of cerebral resistance vessel various mechanisms that regulate the cerebral circulation and jointly determine the brain perfusion.

THE brain, as a vital organ, disproportionately receives about 12% of cardiac output (CO) even though it weighs only 2% of the body weight.1  Cerebral blood flow (CBF) is regulated by a set of powerful mechanisms that include cerebral autoregulation,2  neurovascular coupling,3  and cerebrovascular carbon dioxide and oxygen reactivity.4  It is common to presume that a stable blood pressure or a fluctuating blood pressure as long as it is within the autoregulatory range will not lead to a noticeable change in CBF according to cerebral autoregulation. However, evidence shows that, even though the blood pressure remains stable or within the autoregulatory range, an alteration in CO, either acutely5–9  or chronically,10–19  leads to a change in CBF. Thus, it is pertinent to understand the effect of CO on CBF within the framework of cerebral autoregulation, a mechanism describing the effect of cerebral perfusion pressure on CBF.

Optimal organ perfusion is fundamental to avoiding tissue ischemia and overperfusion. There are two common theories to explain the relationship between organ perfusion and systemic hemodynamics. The first is based on an analogy to Ohm’s law: organ perfusion depends on arterial blood pressure and vascular resistance of the organ. The other is based on the distribution of CO: the blood flow of each organ is a portion of CO that is determined by the value of CO and the percentage of share based on the organ’s metabolic need.1 

The effect of CO on CBF is a topic that has not been reviewed specifically. However, it is a clinically relevant issue because both acute and chronic changes in CO are frequently encountered in clinical care. In addition, it seems that a revision of the traditional framework of cerebral autoregulation is needed to integrate the effects of cerebral perfusion pressure and CO on brain perfusion in one concordant context. This is an important consideration because blood pressure and CO are related but different systemic hemodynamic parameters, and they usually change simultaneously and may exert distinctive effects on brain perfusion.20 

The aims of this review are (1) to examine the evidence of the association between CO and CBF under varying conditions in adult humans, (2) to present a revised conceptual framework that integrates different regulatory mechanisms of brain perfusion, and (3) to discuss the relevant clinical implications.

Effect of Acute Change in CO on CBF

Evidence

A distinct association between CO and CBF was demonstrated in young healthy volunteers whose central blood volume was decreased via lower body negative pressure5,7–9  or standing up6  and increased via leg tensing,6  albumin infusion,8  or normal saline infusion9  (table 1). Each percentage change in CO corresponded to a 0.35% change in CBF, that is, there is about a 10% CBF decrease for a 30% CO reduction based on eight data pairs from five previous studies (R2 = 0.9, fig. 1). This association was unlikely to have been confounded by a change in either blood pressure or carbon dioxide because both parameters remained relatively stable except two studies in which carbon dioxide had a clinically significant drop after standing up6  and lower body negative pressure,7  respectively. It was also unlikely to be ascribed to a change in cerebral metabolic activity, because these studies were done in resting and unanesthetized subjects. Therefore, the association between CO and CBF is a causal relationship. The finding that β1-adrenergic blockade concurrently attenuated the increase in both CO and CBF induced by cycling corroborates this proposition.21 

Table 1.

Studies Investigating Simultaneous Changes in Cardiac Output and Cerebral Blood Flow via Central Blood Volume Alteration in Unanesthetized Healthy Volunteers

Studies Investigating Simultaneous Changes in Cardiac Output and Cerebral Blood Flow via Central Blood Volume Alteration in Unanesthetized Healthy Volunteers
Studies Investigating Simultaneous Changes in Cardiac Output and Cerebral Blood Flow via Central Blood Volume Alteration in Unanesthetized Healthy Volunteers
Fig. 1.

Correlation between changes in cardiac output (CO) and cerebral blood flow (CBF) in unanesthetized healthy volunteers during central blood volume alterations.5–9  All data are reported in table 1. The diameter of the dot represents the sample size that is also indicated by the number inside of each dot.

Fig. 1.

Correlation between changes in cardiac output (CO) and cerebral blood flow (CBF) in unanesthetized healthy volunteers during central blood volume alterations.5–9  All data are reported in table 1. The diameter of the dot represents the sample size that is also indicated by the number inside of each dot.

However, differences among the methodologies used to alter CO and measure CO and CBF should be considered during data interpretation. In these studies, the CO was altered via an acute change in central blood volume using different maneuvers, and the CO was measured using different methods even though the CBF was always assessed using transcranial Doppler (TCD; table 1). There is a chance that methodologic heterogeneity could cause inconsistent results. In addition, the practice of using TCD-measured middle cerebral artery blood flow velocity as a CBF surrogate has been cautioned against, especially in patients with cerebrovascular diseases.22,23 

In contrast, a recent study failed to define an association between cardiac index and CBF with both parameters measured using magnetic resonance imaging techniques in 31 healthy subjects of 50 to 75 yr.24  There are a multitude of differences between this study and the previous studies summarized in table 1. The most prominent is that the CO (and CBF as a consequence) was not acutely altered compared with that of the previous studies. It is worth noting that the fractional CBF, defined as the ratio of CBF to CO, was inversely correlated with cardiac index (R2 = 0.22, P = 0.008), implying that when the CO is decreased, the brain shares an increasing percentage of CO.24 

Mechanism

When the CBF was changed during acute central blood volume alteration, there must be a change in cerebrovascular resistance to account for the flow change because the blood pressure remained relatively stable. Indeed, three of four studies showed an increase in cerebrovascular resistance assessed using TCD pulsatility ratio during lower body negative pressure,5,7,8  and two studies showed a decrease during albumin or normal saline infusion.8,9  The common causes of a change in cerebrovascular resistance are (1) a change in cerebral perfusion pressure via autoregulation,2  (2) a change in cerebral metabolic activity via neurovascular coupling,3  (3) a change in arterial blood carbon dioxide partial pressure via ventilation change,25  and (4) a change in sympathetic nervous activity via the sympathetic innervation of the cerebral resistance vessels.26  The first three options are essentially excluded based on the study conditions.5,7–9  Therefore, by exclusion, this attributes the increase in cerebrovascular resistance to the sympathoexcitation incurred by central blood volume alteration.8 

During acute central blood volume alteration, the extent of the CBF change is much smaller (about one third) than the change in peripheral regional blood flow.5,8  This may be because of either the relatively minor role the sympathetic nervous system plays in the brain perfusion compared with the periphery26–29  or the countering effects by other robust CBF-regulating mechanisms that the periphery lacks. Physiologically, the differential extent of vasoconstriction in different vascular beds shunts the flow from the periphery to the brain because brain perfusion is a priority during acute CO reduction.

However, direct evidence of how the simultaneous acute changes in CO and CBF are mediated by the sympathetic nervous system is lacking, and therefore, the mechanism(s) responsible for the acute change in CBF because of an acute change in CO remains largely speculative.

Effect of Chronically Reduced CO on CBF

Evidence

Extensive evidence shows that CBF is reduced in patients diagnosed with chronic heart failure compared with that of control who do not have cardiac insufficiency (table 2).10–19  The extent of the CBF reduction correlates with the severity of the chronic heart failure assessed using New York Heart Association functional classification14  and left ventricular ejection fraction.18  The CBF reduction is reversed by interventions including cardiac transplantation,13–15  cardiac resynchronization therapy,17,19  cardioversion,30  and captopril treatment10–12  (fig. 2). Overall, a causal relationship between CO and CBF in patients with chronic heart failure is implied. This proposition is corroborated by a recent study that showed an exaggerated cerebral hypoperfusion in the upright posture in patients with heart failure compared with age- and sex-matched healthy controls.31 

Table 2.

Cerebral Blood Flow at Baseline and/or after Various Interventions in Patients with Chronic Heart Failure

Cerebral Blood Flow at Baseline and/or after Various Interventions in Patients with Chronic Heart Failure
Cerebral Blood Flow at Baseline and/or after Various Interventions in Patients with Chronic Heart Failure
Fig. 2.

Cerebral blood flow in patients diagnosed with chronic heart failure (CHF) before (preintervention) and after (postintervention) various interventions.10–14  The control was from patients without cardiac insufficiency. All data are reported in table 2. Only the studies that reported the control, preintervention, and postintervention values of cerebral blood flow in the units of ml min−1 100 g−1 were included. The dots with the same color are from the same study. The diameter of the dot represents the sample size that is also indicated by the number inside of each dot.

Fig. 2.

Cerebral blood flow in patients diagnosed with chronic heart failure (CHF) before (preintervention) and after (postintervention) various interventions.10–14  The control was from patients without cardiac insufficiency. All data are reported in table 2. Only the studies that reported the control, preintervention, and postintervention values of cerebral blood flow in the units of ml min−1 100 g−1 were included. The dots with the same color are from the same study. The diameter of the dot represents the sample size that is also indicated by the number inside of each dot.

However, the methodologic heterogeneity and limitations of these studies should be recognized. The sample size in the intervention studies, especially those with cardiac transplantation, was small.13–15  The increased blood pressure after cardiac transplantation can confound the interpretation of the effect of improved CO on CBF.13,15  In rodents, captopril treatment can further reduce the lower limit of cerebral autoregulation after nephrectomy,32  decrease infarction size via CBF improvement after ischemic stroke,33  and restore cerebral autoregulation after hemorrhagic stroke.34  Therefore, studies with captopril treatment can be confounded by the direct effect of captopril on CBF regulation.10–12 

Mechanism

The mechanism underlying the CBF reduction in patients with chronic heart failure is unclear but likely related to the neurohormonal activation incurred by a failing heart. The hyperactivity of both the sympathetic nervous system and the renin–angiotensin–aldosterone axis provokes vasoconstriction of not only the peripheral vascular beds but also the cerebral vascular bed.35–38  The circulating and locally formed angiotensin II may contribute to the decrease of CBF via the AT1 receptors expressed in cerebrovascular endothelial cells and in the brain regions controlling cerebral circulation.39  Similar to the effect of acute CO reduction on CBF, the differential extent of vasoconstriction of different vascular beds shunts the flow from the periphery to the brain in patients with chronic heart failure, resulting in a lesser extent of CBF reduction than both the CO and the peripheral blood flow.35 

Neurocognitive Impairment

A relevant question that deserves discussion is what the consequences of the reduced cerebral perfusion are in patients with chronic heart failure. It is counterintuitive to assume that long-term suboptimal brain perfusion is inconsequential. Indeed, abundant evidence shows that the prevalence of cognitive dysfunction is inappropriately high in patients diagnosed with chronic heart failure.40–45  The odds ratio for cognitive impairment in patients with chronic heart failure is 1.62 with the 95% CI of 1.48 to 1.79 (P < 0.0001) based on a systematic review.43  The extent of cognitive impairment parallels the severity of chronic heart failure.42,44,46  Both cardiac resynchronization therapy47,48  and transplantation49,50  improved the impaired cognition.

Chronic heart failure is also linked to abnormal brain aging and Alzheimer disease.51–54  The relentless cerebral hypoperfusion and neurohormonal hyperactivity likely contribute to the dysfunction of the neurovascular unit.53,54  The neuronal energy crisis facilitates protein synthesis abnormalities that include impaired clearance of amyloid β and hyperphosphorylation of τ protein, ending up with the formation of amyloid-β plaques and neurofibrillary tangles.54,55 

Despite the plausible notion that there is a link among chronic heart failure, cerebral hypoperfusion, and neurocognitive dysfunction, caution is needed before claiming a causal relationship because these chronic conditions share risk factors. In addition, not every patient with neurocognitive impairment has chronic heart failure and vice versa.

Disease States Demonstrating CO–CBF Association

Vasospasm

The goal in treating vasospasm induced by subarachnoid hemorrhage is to restore the reduced CBF. One of the strategies is to augment the CO with the hope of improving the cerebral perfusion. A clinical study found that a 46% increase in CO via dobutamine infusion led to a significant increase in CBF (from 25 to 35 ml min−1 100 g−1) in the brain regions perfused by the vasospastic arteries.56  The increase in cerebral perfusion took place despite a decrease in mean arterial pressure from 113 to 108 mmHg. The result of this study was corroborated in a separate study that showed the clinical reversal of the ischemic symptoms by dobutamine infusion combined with hypervolemic preloading in 78% of symptomatic patients.57  Intraaortic balloon pump counterpulsation has also been tested in this patient population. In a report of 15 cases in which this treatment was used in patients who also had neurogenic stress cardiomyopathy, it was concluded that the use of intraaortic balloon pump counterpulsation was effective in preventing the delayed ischemic neurologic deficits.58 

Ischemic Stroke

In patients with acute ischemic stroke in the middle cerebral artery territory, an association between CO and TCD-estimated CBF was demonstrated in the affected, but not the unaffected, brain region when using hypervolemic hemodilution combined with dopamine–dobutamine infusions.59  Intraaortic balloon pump counterpulsation was also found to increase TCD-estimated CBF by 21 and 11% in patients with acute ischemic stroke whose left ventricular ejection fractions were 28 and 44%, respectively.60  Intraaortic balloon pump counterpulsation normally decreases systolic blood pressure, increases diastolic blood pressure, and produces little or no change in mean blood pressure in normotensive patients.61  Therefore, it is reasonable to attribute the improvement of the CBF to the augmentation of the CO during the application of intraaortic balloon pump counterpulsation.

Sepsis

In studies conducted in septic patients, dobutamine infusion increased both cardiac index (from 3.4 to 4.2 l min−1 m−2 and from 3.8 to 6.3 l min−1 m−2) and TCD-estimated CBF (from 52 to 62 cm/s and from 68 to 80 cm/s), whereas the increase in mean arterial pressure was from 85 to 91 mmHg and from 77 to 86 mmHg, respectively.62,63  Both studies showed a better correlation between CO and CBF than between blood pressure and CBF using both the relative changes of parameters63  and the absolute values of measurements.62 

Disease States Demonstrating a Lack of CO–CBF Association

Head Injury

An association between changes in CO and CBF (133Xe washout) was not found during treatment with phenylephrine, trimethaphan or mannitol in comatose and ventilated patients with severe head injury.64  Phenylephrine, which is a peripheral vasoconstrictor used to increase blood pressure, actually causes a decrease in CO.20  This may have confounded the study. An increase in perfusion pressure can lead to an increase in CBF in neurologically critically ill patients who have impaired autoregulation65 ; as a result, phenylephrine treatment likely causes opposite changes in CBF (increase) and CO (decrease).

Neurologic Surgery

CBF is normally increased after surgical resection of brain arteriovenous malformations. However, an association between changes in CO and CBF (133Xe washout) based on the preresection and postresection measurements was not found in this patient population.66  Hemodynamic variables including CO, arterial blood pressure, central venous pressure, and pulmonary artery diastolic pressure remained stable in the face of the increase in CBF. Brain arteriovenous malformations have unique hemodynamic physiology including the relatively low transnidal pressure gradient that may shunt a portion of CBF through the lesion.67  Thus, it is speculated that after surgical resection, the portion of CBF originally going through the arteriovenous malformation reroutes through the normal brain resulting in a regionally increased CBF in the face of unchanged systemic hemodynamics.

Cardiac Surgery

Cardiac surgery with cardiopulmonary bypass is a special situation in which organ perfusion is propelled by an extracorporeal centrifugal pump. How the pump flow affects the cerebral perfusion depends on the blood gas management.68  With α-stat management, CBF (133Xe washout) is correlated with blood pressure, not pump flow.69  With pH-stat management, CBF (argon saturation and desaturation method) is correlated with pump flow in the face of a stable blood pressure.70  The precise mechanism(s) underlying this discrepancy is unclear. The cerebral vasodilation induced by hypercapnia may be responsible, because carbon dioxide is often added during pH-stat management but not during α-stat management.71  Hypothermic cardiopulmonary bypass suppresses sympathetic nervous activity72  and that may also alter the association between CO and CBF.

Hepatic Failure

An association between CO and CBF (133Xe washout) was not found in patients with fulminant hepatic failure.73  However, this study was underpowered with only eight pairs of data, and the statistical insignificance likely reflects a single outlier. This study also found that the norepinephrine-induced changes in CO and TCD-estimated CBF did not correlate with each other. However, norepinephrine primarily increases blood pressure and has unpredictable effects on CO.74  Therefore, the study was confounded by the simultaneous change in blood pressure.

Cardiology

A study performed in patients with coronary heart disease or cardiomyopathy referred for echocardiography failed to show an association between CO and CBF.75  However, the study was confounded by the use of common carotid artery blood flow measured using color M-mode duplex system as a surrogate for CBF as the external carotid artery blood flow is included.

Integrated Regulation of CBF

CBF is rigorously regulated by multiple powerful mechanisms to safeguard the matching of cerebral metabolic demand and supply.76  CO is one of the physiologic processes that contribute to CBF regulation. However, exactly how an alteration in CO, in the face of a stable blood pressure, leads to a change in CBF is not entirely clear. A proposal that integrates various CBF-regulating mechanisms, including the role of blood pressure and CO, in one concordant conceptualization seems necessary.

A conceptual framework of the integrated regulation of the brain perfusion is proposed (fig. 3). It needs to be appreciated that the various mechanisms, no matter how distinctive, all exert their regulatory effects on the same target, that is, the cerebral resistance vessels. Different mechanisms may affect different segments of the cerebral resistance vessels. For example, sympathetic stimulation constricts large cerebral arteries, whereas an increase in blood pressure constricts the arterioles.77  The various CBF-regulating mechanisms integrate at the level of the cerebral resistance vessels and generate only one consequence that is the extent of the cerebrovascular resistance. Therefore, how CBF is changed after a change in any of the regulatory processes depends on how the different mechanisms are integrated. Different mechanisms likely have different degrees of regulatory power likely determined by the physiologic priority in the context of the clinical situation. The one with the major regulatory power plays a dominant role, whereas one with minor power plays a smaller role.

Fig. 3.

The conceptual framework of the integrated regulation of brain perfusion. The cerebrovascular resistance determined by the caliber of the cerebral resistance vessels is regulated by various physiologic processes: (1) cardiac output (CO) likely via sympathetic nervous activity (SNA) and renin–angiotensin–aldosterone (RAA) system, depending on the chronicity of the change in CO,5–19  (2) arterial blood pressure (ABP) and cerebral perfusion pressure (CPP) via cerebral autoregulation,2,71  (3) cerebral metabolic activity via neurovascular coupling,3,76  and (4) arterial blood carbon dioxide (CO2)4,25,71  and oxygen (O2)4 via cerebrovascular reactivity. The SNA regulates cerebral blood flow26–29  and may play a prominent role during acute hypertension and hypercapnia29  as a protective mechanism preventing cerebral overperfusion (dashed line). These various regulatory mechanisms, together with other CBF-regulatory mechanisms that are not specified here such as anesthetic effects, integrate at the level of the cerebral resistance vessels and generate only one consequence, which is the extent of the cerebrovascular resistance and, therefore, jointly regulate brain perfusion. The plateau of the autoregulation curve shifts downward when the CO is reduced and upward when augmented. The position of the plateau is determined by the caliber (R) of the cerebral resistance vessels at high (Rhigh), normal (Rnorm), and low (Rlow) CO. The scale of CO on the right side is smaller than that of CBF on the left side to reflect the lesser extent of change in CBF induced by an alteration of CO.

Fig. 3.

The conceptual framework of the integrated regulation of brain perfusion. The cerebrovascular resistance determined by the caliber of the cerebral resistance vessels is regulated by various physiologic processes: (1) cardiac output (CO) likely via sympathetic nervous activity (SNA) and renin–angiotensin–aldosterone (RAA) system, depending on the chronicity of the change in CO,5–19  (2) arterial blood pressure (ABP) and cerebral perfusion pressure (CPP) via cerebral autoregulation,2,71  (3) cerebral metabolic activity via neurovascular coupling,3,76  and (4) arterial blood carbon dioxide (CO2)4,25,71  and oxygen (O2)4 via cerebrovascular reactivity. The SNA regulates cerebral blood flow26–29  and may play a prominent role during acute hypertension and hypercapnia29  as a protective mechanism preventing cerebral overperfusion (dashed line). These various regulatory mechanisms, together with other CBF-regulatory mechanisms that are not specified here such as anesthetic effects, integrate at the level of the cerebral resistance vessels and generate only one consequence, which is the extent of the cerebrovascular resistance and, therefore, jointly regulate brain perfusion. The plateau of the autoregulation curve shifts downward when the CO is reduced and upward when augmented. The position of the plateau is determined by the caliber (R) of the cerebral resistance vessels at high (Rhigh), normal (Rnorm), and low (Rlow) CO. The scale of CO on the right side is smaller than that of CBF on the left side to reflect the lesser extent of change in CBF induced by an alteration of CO.

The effect of CO on CBF can be appreciated within the framework of cerebral autoregulation (fig. 3). When CO is decreased, the plateau descends slightly reflecting the smaller decrease in CBF, and vice versa; however, the overall autoregulatory mechanism is maintained. This proposition is corroborated by the finding that dynamic cerebral autoregulation is not affected by the acute change in CO.78  Thus, this speculative proposal integrates the effects of blood pressure and CO on brain perfusion. However, how the lower and upper limits of the autoregulation curve are changed and whether the plateau tilts when the CO is altered are unknown.

The lesser extent to which CBF changes compared with that of CO or peripheral blood flow during acute or chronic CO alterations can be explained by the fact that the extent to which CBF is changed is determined by the integrated effect of all CBF-regulating mechanisms. Other powerful CBF-regulating mechanisms unrelated to CO may buffer the effect of CO on CBF, causing a lesser flow change in the brain compared with the organs that are not influenced by these mechanisms.

Clinical Implications

Acute changes in CO because of a variety of etiologies such as dehydration, blood loss, body tilt, mechanical ventilation, intraabdominal insufflation, pneumothorax, hemothorax, diuresis, vasodilation, sympatholysis, anesthetic agent, pulmonary embolization, myocardial infarction, and arrhythmia are frequently encountered in the operating room. CBF may decrease when the CO is reduced. Therefore, for the purpose of maintaining CBF, any adverse change in CO should be remedied. Goal-directed fluid therapy for the purpose of CO optimization has been shown to be associated with an improved overall outcome after intraabdominal surgeries.79,80  However, to what degree this favorable outcome is attributable to the optimization of CBF is unknown.

It seems reasonable to advocate intraoperative monitoring of both CO and CBF in patients with reduced cardiac function or cerebrovascular obstructive diseases or during high-risk surgeries that have a greater chance of causing hemodynamic fluctuation. The currently unanswered question is how best to monitor both parameters continuously and noninvasively and which patient populations benefit the most from this strategy of care.

In the perioperative setting, it needs to be emphasized that the cerebral circulation is affected by multiple processes, and CO is one of them. Anesthesia itself affects cerebral perfusion via a variety of pathways that include the suppression of cerebral metabolic activity,81  intrinsic cerebral vasodilation by volatile agents,82  impairment of cerebral autoregulation by volatile agents,83  suppression of the sympathetic nervous activity,84  and disturbance of the systemic hemodynamics.85  Therefore, the association between CO and CBF learned from studies performed in unanesthetized healthy volunteers may not always apply in the anesthetized surgical patients.

Chronic heart failure is prevalent affecting approximately 2% of the adult population and is associated with a high mortality.86  Its prevalence increases sharply with age, affecting 10% of the population aged 65 yr or older.87  An increasing number of patients diagnosed with chronic heart failure are expected to present to the operating room for surgery, and this poses a great challenge for perioperative care. It is judicious to avoid acute reductions of both CO and CBF on top of the chronic cardiac insufficiency and cerebral hypoperfusion. This mandates thoughtful preoperative preparation, adept appreciation of cardiovascular and cerebrovascular physiology and their interaction, and preemptively preventing circumstances that threaten cardiac performance and brain perfusion.

Studies on the association between CO and CBF in patients with major neurologic, medical, or surgical conditions are confounded by methodologic limitations. However, it seems that interventions that enhance cardiac performance may improve perfusion of the ischemic brain, especially in patients with impaired cardiac function (fig. 2).56–60  It is important although to remember that drugs that increase blood pressure such as phenylephrine and norepinephrine may actually decrease CO.20,74  In contrast, dobutamine and volume augmentation can increase the CO but not necessarily blood pressure. The effect of a vasopressor on CBF likely depends on the drug being used, the disease state, and the functional status of the regulatory mechanisms of brain perfusion.88,89  Currently, long-term outcome data relevant to the choice of vasopressor in various clinical situations is lacking.

The proposed conceptualization integrating various CBF-regulating mechanisms within the framework of cerebral autoregulation has important clinical implications. The habitual thinking that how the brain is perfused is merely dependent on the blood pressure should be abandoned. The autoregulatory curve should be regarded as a dynamic process, meaning that its shape, plateau, and the lower and upper limits may change depending on the integrated effect of nonpressure but CBF-regulating mechanisms including the CO.71  For a given value of blood pressure, even though it is deemed clinically acceptable, the CBF may be either higher or lower than that estimated by the traditional autoregulatory curve. Therefore, the management of CBF should be guided by a multifactorial but integrated framework of CBF regulation, especially in patients who are at risk of cerebral ischemia.

Overall, these recommendations are largely based on physiologic studies in healthy volunteers and patients with chronic heart failure or other diagnoses. Meaningful outcome research pertinent to the management of CO and CBF is needed to better guide clinical practice. Moreover, noninvasive or minimally invasive, reliable, and continuous CO monitoring, as well as CBF monitoring or its surrogates, need to be considered for use in high-risk patients or during high-risk surgeries.

Summary

As one of the most important systemic hemodynamic parameters, CO contributes to the regulation of CBF likely via the sympathetic nervous activity, with or without the renin–angiotensin system depending on the acuteness or chronicity of change. The various mechanisms that regulate the cerebral circulation integrate at the level of the cerebral resistance vessels and jointly determine the brain perfusion. The effect of CO on brain perfusion should be integrated into the framework of cerebral autoregulation. The clinical considerations are confounded by methodologic limitations. Interventions aimed at enhancing cardiac performance and improving brain perfusion need to be tested by relevant clinical outcomes research.

Acknowledgments

This study was supported by the Inaugural Anesthesia Department Awards for Seed Funding for Clinically Oriented Research Projects from the Department of Anesthesia and Perioperative Care, University of California San Francisco, San Francisco, California (to Dr. Meng).

Competing Interests

The authors declare no competing interests.

References

1.
Williams
LR
,
Leggett
RW
:
Reference values for resting blood flow to organs of man.
Clin Phys Physiol Meas
1989
;
10
:
187
217
2.
Paulson
OB
,
Strandgaard
S
,
Edvinsson
L
:
Cerebral autoregulation.
Cerebrovasc Brain Metab Rev
1990
;
2
:
161
92
3.
Girouard
H
,
Iadecola
C
:
Neurovascular coupling in the normal brain and in hypertension, stroke, and Alzheimer disease.
J Appl Physiol
2006
;
100
:
328
35
4.
Kety
SS
,
Schmidt
CF
:
The effects of altered arterial tensions of carbon dioxide and oxygen on cerebral blood flow and cerebral oxygen consumption of normal young men.
J Clin Invest
1948
;
27
:
484
92
5.
Levine
BD
,
Giller
CA
,
Lane
LD
,
Buckey
JC
,
Blomqvist
CG
:
Cerebral versus systemic hemodynamics during graded orthostatic stress in humans.
Circulation
1994
;
90
:
298
306
6.
van Lieshout
JJ
,
Pott
F
,
Madsen
PL
,
van Goudoever
J
,
Secher
NH
:
Muscle tensing during standing: Effects on cerebral tissue oxygenation and cerebral artery blood velocity.
Stroke
2001
;
32
:
1546
51
7.
Brown
CM
,
Dütsch
M
,
Hecht
MJ
,
Neundörfer
B
,
Hilz
MJ
:
Assessment of cerebrovascular and cardiovascular responses to lower body negative pressure as a test of cerebral autoregulation.
J Neurol Sci
2003
;
208
:
71
8
8.
Ogoh
S
,
Brothers
RM
,
Barnes
Q
,
Eubank
WL
,
Hawkins
MN
,
Purkayastha
S
,
O-Yurvati
A
,
Raven
PB
:
The effect of changes in cardiac output on middle cerebral artery mean blood velocity at rest and during exercise.
J Physiol
2005
;
569
(
Pt 2
):
697
704
9.
Ogawa
Y
,
Iwasaki
K
,
Aoki
K
,
Shibata
S
,
Kato
J
,
Ogawa
S
:
Central hypervolemia with hemodilution impairs dynamic cerebral autoregulation.
Anesth Analg
2007
;
105
:
1389
96
10.
Rajagopalan
B
,
Raine
AE
,
Cooper
R
,
Ledingham
JG
:
Changes in cerebral blood flow in patients with severe congestive cardiac failure before and after captopril treatment.
Am J Med
1984
;
76
:
86
90
11.
Paulson
OB
,
Jarden
JO
,
Godtfredsen
J
,
Vorstrup
S
:
Cerebral blood flow in patients with congestive heart failure treated with captopril.
Am J Med
1984
;
76
:
91
5
12.
Paulson
OB
,
Jarden
JO
,
Vorstrup
S
,
Holm
S
,
Godtfredsen
J
:
Effect of captopril on the cerebral circulation in chronic heart failure.
Eur J Clin Invest
1986
;
16
:
124
32
13.
Gruhn
N
,
Larsen
FS
,
Boesgaard
S
,
Knudsen
GM
,
Mortensen
SA
,
Thomsen
G
,
Aldershvile
J
:
Cerebral blood flow in patients with chronic heart failure before and after heart transplantation.
Stroke
2001
;
32
:
2530
3
14.
Choi
BR
,
Kim
JS
,
Yang
YJ
,
Park
KM
,
Lee
CW
,
Kim
YH
,
Hong
MK
,
Song
JK
,
Park
SW
,
Park
SJ
,
Kim
JJ
:
Factors associated with decreased cerebral blood flow in congestive heart failure secondary to idiopathic dilated cardiomyopathy.
Am J Cardiol
2006
;
97
:
1365
9
15.
Massaro
AR
,
Dutra
AP
,
Almeida
DR
,
Diniz
RV
,
Malheiros
SM
:
Transcranial Doppler assessment of cerebral blood flow: Effect of cardiac transplantation.
Neurology
2006
;
66
:
124
6
16.
Vogels
RL
,
Oosterman
JM
,
Laman
DM
,
Gouw
AA
,
Schroeder-Tanka
JM
,
Scheltens
P
,
van der Flier
WM
,
Weinstein
HC
:
Transcranial Doppler blood flow assessment in patients with mild heart failure: Correlates with neuroimaging and cognitive performance.
Congest Heart Fail
2008
;
14
:
61
5
17.
van Bommel
RJ
,
Marsan
NA
,
Koppen
H
,
Delgado
V
,
Borleffs
CJ
,
Ypenburg
C
,
Bertini
M
,
Schalij
MJ
,
Bax
JJ
:
Effect of cardiac resynchronization therapy on cerebral blood flow.
Am J Cardiol
2010
;
106
:
73
7
18.
Loncar
G
,
Bozic
B
,
Lepic
T
,
Dimkovic
S
,
Prodanovic
N
,
Radojicic
Z
,
Cvorovic
V
,
Markovic
N
,
Brajovic
M
,
Despotovic
N
,
Putnikovic
B
,
Popovic-Brkic
V
:
Relationship of reduced cerebral blood flow and heart failure severity in elderly males.
Aging Male
2011
;
14
:
59
65
19.
Ozdemir
O
,
Soylu
M
,
Durmaz
T
,
Tosun
O
:
Early haemodynamic changes in cerebral blood flow after cardiac resychronisation therapy.
Heart Lung Circ
2013
;
22
:
260
4
20.
Meng
L
,
Cannesson
M
,
Alexander
BS
,
Yu
Z
,
Kain
ZN
,
Cerussi
AE
,
Tromberg
BJ
,
Mantulin
WW
:
Effect of phenylephrine and ephedrine bolus treatment on cerebral oxygenation in anaesthetized patients.
Br J Anaesth
2011
;
107
:
209
17
21.
Ide
K
,
Pott
F
,
Van Lieshout
JJ
,
Secher
NH
:
Middle cerebral artery blood velocity depends on cardiac output during exercise with a large muscle mass.
Acta Physiol Scand
1998
;
162
:
13
20
22.
Démolis
P
,
Tran Dinh
YR
,
Giudicelli
JF
:
Relationships between cerebral regional blood flow velocities and volumetric blood flows and their respective reactivities to acetazolamide.
Stroke
1996
;
27
:
1835
9
23.
Clyde
BL
,
Resnick
DK
,
Yonas
H
,
Smith
HA
,
Kaufmann
AM
:
The relationship of blood velocity as measured by transcranial doppler ultrasonography to cerebral blood flow as determined by stable xenon computed tomographic studies after aneurysmal subarachnoid hemorrhage.
Neurosurgery
1996
;
38
:
896
904
24.
Henriksen
OM
,
Jensen
LT
,
Krabbe
K
,
Larsson
HB
,
Rostrup
E
:
Relationship between cardiac function and resting cerebral blood flow: MRI measurements in healthy elderly subjects.
Clin Physiol Funct Imaging
2014
;
34
:
471
7
25.
Harper
AM
,
Glass
HI
:
Effect of alterations in the arterial carbon dioxide tension on the blood flow through the cerebral cortex at normal and low arterial blood pressures.
J Neurol Neurosurg Psychiatry
1965
;
28
:
449
52
26.
Cencetti
S
,
Lagi
A
,
Cipriani
M
,
Fattorini
L
,
Bandinelli
G
,
Bernardi
L
:
Autonomic control of the cerebral circulation during normal and impaired peripheral circulatory control.
Heart
1999
;
82
:
365
72
27.
Nelson
E
,
Rennels
M
:
Innervation of intracranial arteries.
Brain
1970
;
93
:
475
90
28.
Edvinsson
L
:
Innervation of the cerebral circulation.
Ann N Y Acad Sci
1987
;
519
:
334
48
29.
ter Laan
M
,
van Dijk
JM
,
Elting
JW
,
Staal
MJ
,
Absalom
AR
:
Sympathetic regulation of cerebral blood flow in humans: A review.
Br J Anaesth
2013
;
111
:
361
7
30.
Petersen
P
,
Kastrup
J
,
Videbaek
R
,
Boysen
G
:
Cerebral blood flow before and after cardioversion of atrial fibrillation.
J Cereb Blood Flow Metab
1989
;
9
:
422
5
31.
Fraser
KS
,
Heckman
GA
,
McKelvie
RS
,
Harkness
K
,
Middleton
LE
,
Hughson
RL
:
Cerebral hypoperfusion is exaggerated with an upright posture in heart failure: Impact of depressed cardiac output.
JACC Heart Fail
2015
;
3
:
168
75
32.
Pedersen
TF
,
Paulson
OB
,
Nielsen
AH
,
Strandgaard
S
:
Effect of nephrectomy and captopril on autoregulation of cerebral blood flow in rats.
Am J Physiol Heart Circ Physiol
2003
;
285
:
H1097
104
33.
Ito
T
,
Yamakawa
H
,
Bregonzio
C
,
Terrón
JA
,
Falcón-Neri
A
,
Saavedra
JM
:
Protection against ischemia and improvement of cerebral blood flow in genetically hypertensive rats by chronic pretreatment with an angiotensin II AT1 antagonist.
Stroke
2002
;
33
:
2297
303
34.
Smeda
JS
,
Daneshtalab
N
:
The effects of poststroke captopril and losartan treatment on cerebral blood flow autoregulation in SHRsp with hemorrhagic stroke.
J Cereb Blood Flow Metab
2011
;
31
:
476
85
35.
Zelis
R
,
Sinoway
LI
,
Musch
TI
,
Davis
D
,
Just
H
:
Regional blood flow in congestive heart failure: Concept of compensatory mechanisms with short and long time constants.
Am J Cardiol
1988
;
62
:
2E
8E
36.
Francis
GS
:
The relationship of the sympathetic nervous system and the renin-angiotensin system in congestive heart failure.
Am Heart J
1989
;
118
:
642
8
37.
Packer
M
:
The neurohormonal hypothesis: A theory to explain the mechanism of disease progression in heart failure.
J Am Coll Cardiol
1992
;
20
:
248
54
38.
Patterson
JH
,
Adams
KF
Jr
:
Pathophysiology of heart failure: Changing perceptions.
Pharmacotherapy
1996
;
16
(
2 Pt 2
):
27S
36S
39.
Saavedra
JM
,
Benicky
J
,
Zhou
J
:
Mechanisms of the anti-ischemic effect of angiotensin II AT(1) receptor antagonists in the brain.
Cell Mol Neurobiol
2006
;
26
:
1099
111
40.
Trojano
L
,
Antonelli Incalzi
R
,
Acanfora
D
,
Picone
C
,
Mecocci
P
,
Rengo
F
;
Congestive Heart Failure Italian Study Investigators
:
Cognitive impairment: A key feature of congestive heart failure in the elderly.
J Neurol
2003
;
250
:
1456
63
41.
Heckman
GA
,
Patterson
CJ
,
Demers
C
,
St Onge
J
,
Turpie
ID
,
McKelvie
RS
:
Heart failure and cognitive impairment: Challenges and opportunities.
Clin Interv Aging
2007
;
2
:
209
18
42.
Cohen
MB
,
Mather
PJ
:
A review of the association between congestive heart failure and cognitive impairment.
Am J Geriatr Cardiol
2007
;
16
:
171
4
43.
Vogels
RL
,
Scheltens
P
,
Schroeder-Tanka
JM
,
Weinstein
HC
:
Cognitive impairment in heart failure: A systematic review of the literature.
Eur J Heart Fail
2007
;
9
:
440
9
44.
Debette
S
,
Bauters
C
,
Leys
D
,
Lamblin
N
,
Pasquier
F
,
de Groote
P
:
Prevalence and determinants of cognitive impairment in chronic heart failure patients.
Congest Heart Fail
2007
;
13
:
205
8
45.
Sauvé
MJ
,
Lewis
WR
,
Blankenbiller
M
,
Rickabaugh
B
,
Pressler
SJ
:
Cognitive impairments in chronic heart failure: A case controlled study.
J Card Fail
2009
;
15
:
1
10
46.
Putzke
JD
,
Williams
MA
,
Rayburn
BK
,
Kirklin
JK
,
Boll
TJ
:
The relationship between cardiac function and neuropsychological status among heart transplant candidates.
J Card Fail
1998
;
4
:
295
303
47.
Conti
JB
,
Sears
SF
:
Cardiac resynchronization therapy: Can we make our heart failure patients smarter?
Trans Am Clin Climatol Assoc
2007
;
118
:
153
64
48.
Dixit
NK
,
Vazquez
LD
,
Cross
NJ
,
Kuhl
EA
,
Serber
ER
,
Kovacs
A
,
Dede
DE
,
Conti
JB
,
Sears
SF
:
Cardiac resynchronization therapy: A pilot study examining cognitive change in patients before and after treatment.
Clin Cardiol
2010
;
33
:
84
8
49.
Bornstein
RA
,
Starling
RC
,
Myerowitz
PD
,
Haas
GJ
:
Neuropsychological function in patients with end-stage heart failure before and after cardiac transplantation.
Acta Neurol Scand
1995
;
91
:
260
5
50.
Roman
DD
,
Kubo
SH
,
Ormaza
S
,
Francis
GS
,
Bank
AJ
,
Shumway
SJ
:
Memory improvement following cardiac transplantation.
J Clin Exp Neuropsychol
1997
;
19
:
692
7
51.
Jefferson
AL
,
Himali
JJ
,
Beiser
AS
,
Au
R
,
Massaro
JM
,
Seshadri
S
,
Gona
P
,
Salton
CJ
,
DeCarli
C
,
O’Donnell
CJ
,
Benjamin
EJ
,
Wolf
PA
,
Manning
WJ
:
Cardiac index is associated with brain aging: The Framingham Heart Study.
Circulation
2010
;
122
:
690
7
52.
Jefferson
AL
,
Himali
JJ
,
Au
R
,
Seshadri
S
,
Decarli
C
,
O’Donnell
CJ
,
Wolf
PA
,
Manning
WJ
,
Beiser
AS
,
Benjamin
EJ
:
Relation of left ventricular ejection fraction to cognitive aging (from the Framingham Heart Study).
Am J Cardiol
2011
;
108
:
1346
51
53.
de la Torre
JC
:
Cardiovascular risk factors promote brain hypoperfusion leading to cognitive decline and dementia.
Cardiovasc Psychiatry Neurol
2012
;
2012
:
367516
54.
Cermakova
P
,
Eriksdotter
M
,
Lund
LH
,
Winblad
B
,
Religa
P
,
Religa
D
:
Heart failure and Alzheimer’s disease.
J Intern Med
2015
;
277
:
406
25
55.
de la Torre
JC
:
Pathophysiology of neuronal energy crisis in Alzheimer’s disease.
Neurodegener Dis
2008
;
5
:
126
32
56.
Kim
DH
,
Joseph
M
,
Ziadi
S
,
Nates
J
,
Dannenbaum
M
,
Malkoff
M
:
Increases in cardiac output can reverse flow deficits from vasospasm independent of blood pressure: A study using xenon computed tomographic measurement of cerebral blood flow.
Neurosurgery
2003
;
53
:
1044
51
57.
Levy
ML
,
Rabb
CH
,
Zelman
V
,
Giannotta
SL
:
Cardiac performance enhancement from dobutamine in patients refractory to hypervolemic therapy for cerebral vasospasm.
J Neurosurg
1993
;
79
:
494
9
58.
Lazaridis
C
,
Pradilla
G
,
Nyquist
PA
,
Tamargo
RJ
:
Intra-aortic balloon pump counterpulsation in the setting of subarachnoid hemorrhage, cerebral vasospasm, and neurogenic stress cardiomyopathy. Case report and review of the literature.
Neurocrit Care
2010
;
13
:
101
8
59.
Treib
J
,
Haass
A
,
Koch
D
,
Grauer
MT
,
Stoll
M
,
Schimrigk
K
:
Influence of blood pressure and cardiac output on cerebral blood flow and autoregulation in acute stroke measured by TCD.
Eur J Neurol
1996
;
3
:
539
43
60.
Pfluecke
C
,
Christoph
M
,
Kolschmann
S
,
Tarnowski
D
,
Forkmann
M
,
Jellinghaus
S
,
Poitz
DM
,
Wunderlich
C
,
Strasser
RH
,
Schoen
S
,
Ibrahim
K
:
Intra-aortic balloon pump (IABP) counterpulsation improves cerebral perfusion in patients with decreased left ventricular function.
Perfusion
2014
;
29
:
511
6
61.
Trost
JC
,
Hillis
LD
:
Intra-aortic balloon counterpulsation.
Am J Cardiol
2006
;
97
:
1391
8
62.
Berré
J
,
De Backer
D
,
Moraine
JJ
,
Vincent
JL
,
Kahn
RJ
:
Effects of dobutamine and prostacyclin on cerebral blood flow velocity in septic patients.
J Crit Care
1994
;
9
:
1
6
63.
Berré
J
,
De Backer
D
,
Moraine
JJ
,
Mélot
C
,
Kahn
RJ
,
Vincent
JL
:
Dobutamine increases cerebral blood flow velocity and jugular bulb hemoglobin saturation in septic patients.
Crit Care Med
1997
;
25
:
392
8
64.
Bouma
GJ
,
Muizelaar
JP
:
Relationship between cardiac output and cerebral blood flow in patients with intact and with impaired autoregulation.
J Neurosurg
1990
;
73
:
368
74
65.
Engelborghs
K
,
Haseldonckx
M
,
Van Reempts
J
,
Van Rossem
K
,
Wouters
L
,
Borgers
M
,
Verlooy
J
:
Impaired autoregulation of cerebral blood flow in an experimental model of traumatic brain injury.
J Neurotrauma
2000
;
17
:
667
77
66.
Hashimoto
T
,
Young
WL
,
Prohovnik
I
,
Gupta
DK
,
Ostapkovich
ND
,
Ornstein
E
,
Halim
AX
,
Quick
CM
:
Increased cerebral blood flow after brain arteriovenous malformation resection is substantially independent of changes in cardiac output.
J Neurosurg Anesthesiol
2002
;
14
:
204
8
67.
Young
WL
,
Kader
A
,
Pile-Spellman
J
,
Ornstein
E
,
Stein
BM
:
Arteriovenous malformation draining vein physiology and determinants of transnidal pressure gradients. The Columbia University AVM Study Project.
Neurosurgery
1994
;
35
:
389
95
68.
Schell
RM
,
Kern
FH
,
Greeley
WJ
,
Schulman
SR
,
Frasco
PE
,
Croughwell
ND
,
Newman
M
,
Reves
JG
:
Cerebral blood flow and metabolism during cardiopulmonary bypass.
Anesth Analg
1993
;
76
:
849
65
69.
Schwartz
AE
,
Sandhu
AA
,
Kaplon
RJ
,
Young
WL
,
Jonassen
AE
,
Adams
DC
,
Edwards
NM
,
Sistino
JJ
,
Kwiatkowski
P
,
Michler
RE
:
Cerebral blood flow is determined by arterial pressure and not cardiopulmonary bypass flow rate.
Ann Thorac Surg
1995
;
60
:
165
9
70.
Soma
Y
,
Hirotani
T
,
Yozu
R
,
Onoguchi
K
,
Misumi
T
,
Kawada
K
,
Inoue
T
:
A clinical study of cerebral circulation during extracorporeal circulation.
J Thorac Cardiovasc Surg
1989
;
97
:
187
93
71.
Meng
L
,
Gelb
AW
:
Regulation of cerebral autoregulation by carbon dioxide.
Anesthesiology
2015
;
122
:
196
205
72.
Tokunaga
S
,
Imaizumi
T
,
Fukae
K
,
Nakashima
A
,
Hisahara
M
,
Tominaga
R
,
Takeshita
A
,
Yasui
H
,
Tokunaga
K
:
Effects of hypothermia during cardiopulmonary bypass and circulatory arrest on sympathetic nerve activity in rabbits.
Cardiovasc Res
1996
;
31
:
769
76
73.
Larsen
FS
,
Strauss
G
,
Knudsen
GM
,
Herzog
TM
,
Hansen
BA
,
Secher
NH
:
Cerebral perfusion, cardiac output, and arterial pressure in patients with fulminant hepatic failure.
Crit Care Med
2000
;
28
:
996
1000
74.
Maas
JJ
,
Pinsky
MR
,
de Wilde
RB
,
de Jonge
E
,
Jansen
JR
:
Cardiac output response to norepinephrine in postoperative cardiac surgery patients: Interpretation with venous return and cardiac function curves.
Crit Care Med
2013
;
41
:
143
50
75.
Eicke
BM
,
von Schlichting
J
,
Mohr-Ahaly
S
,
Schlosser
A
,
von Bardeleben
RS
,
Krummenauer
F
,
Hopf
HC
:
Lack of association between carotid artery volume blood flow and cardiac output.
J Ultrasound Med
2001
;
20
:
1293
8
76.
Bor-Seng-Shu
E
,
Kita
WS
,
Figueiredo
EG
,
Paiva
WS
,
Fonoff
ET
,
Teixeira
MJ
,
Panerai
RB
:
Cerebral hemodynamics: Concepts of clinical importance.
Arq Neuropsiquiatr
2012
;
70
:
352
6
77.
Baumbach
GL
,
Heistad
DD
:
Effects of sympathetic stimulation and changes in arterial pressure on segmental resistance of cerebral vessels in rabbits and cats.
Circ Res
1983
;
52
:
527
33
78.
Deegan
BM
,
Devine
ER
,
Geraghty
MC
,
Jones
E
,
Ólaighin
G
,
Serrador
JM
:
The relationship between cardiac output and dynamic cerebral autoregulation in humans.
J Appl Physiol
2010
;
109
:
1424
31
79.
Gan
TJ
,
Soppitt
A
,
Maroof
M
,
el-Moalem
H
,
Robertson
KM
,
Moretti
E
,
Dwane
P
,
Glass
PS
:
Goal-directed intraoperative fluid administration reduces length of hospital stay after major surgery.
Anesthesiology
2002
;
97
:
820
6
80.
Wakeling
HG
,
McFall
MR
,
Jenkins
CS
,
Woods
WG
,
Miles
WF
,
Barclay
GR
,
Fleming
SC
:
Intraoperative oesophageal Doppler guided fluid management shortens postoperative hospital stay after major bowel surgery.
Br J Anaesth
2005
;
95
:
634
42
81.
Stullken
EH
Jr
,
Milde
JH
,
Michenfelder
JD
,
Tinker
JH
:
The nonlinear responses of cerebral metabolism to low concentrations of halothane, enflurane, isoflurane, and thiopental.
Anesthesiology
1977
;
46
:
28
34
82.
Matta
BF
,
Mayberg
TS
,
Lam
AM
:
Direct cerebrovasodilatory effects of halothane, isoflurane, and desflurane during propofol-induced isoelectric electroencephalogram in humans.
Anesthesiology
1995
;
83
:
980
5
83.
Strebel
S
,
Lam
AM
,
Matta
B
,
Mayberg
TS
,
Aaslid
R
,
Newell
DW
:
Dynamic and static cerebral autoregulation during isoflurane, desflurane, and propofol anesthesia.
Anesthesiology
1995
;
83
:
66
76
84.
Matsukawa
K
,
Ninomiya
I
,
Nishiura
N
:
Effects of anesthesia on cardiac and renal sympathetic nerve activities and plasma catecholamines.
Am J Physiol
1993
;
265
(
4 Pt 2
):
R792
7
85.
Rusy
BF
,
Komai
H
:
Anesthetic depression of myocardial contractility: A review of possible mechanisms.
Anesthesiology
1987
;
67
:
745
66
86.
Go
AS
,
Mozaffarian
D
,
Roger
VL
,
Benjamin
EJ
,
Berry
JD
,
Borden
WB
,
Bravata
DM
,
Dai
S
,
Ford
ES
,
Fox
CS
,
Franco
S
,
Fullerton
HJ
,
Gillespie
C
,
Hailpern
SM
,
Heit
JA
,
Howard
VJ
,
Huffman
MD
,
Kissela
BM
,
Kittner
SJ
,
Lackland
DT
,
Lichtman
JH
,
Lisabeth
LD
,
Magid
D
,
Marcus
GM
,
Marelli
A
,
Matchar
DB
,
McGuire
DK
,
Mohler
ER
,
Moy
CS
,
Mussolino
ME
,
Nichol
G
,
Paynter
NP
,
Schreiner
PJ
,
Sorlie
PD
,
Stein
J
,
Turan
TN
,
Virani
SS
,
Wong
ND
,
Woo
D
,
Turner
MB
;
American Heart Association Statistics Committee and Stroke Statistics Subcommittee
:
Heart disease and stroke statistics—2013 update: A report from the American Heart Association.
Circulation
2013
;
127
:
e6
245
87.
Roger
VL
,
Go
AS
,
Lloyd-Jones
DM
,
Benjamin
EJ
,
Berry
JD
,
Borden
WB
,
Bravata
DM
,
Dai
S
,
Ford
ES
,
Fox
CS
,
Fullerton
HJ
,
Gillespie
C
,
Hailpern
SM
,
Heit
JA
,
Howard
VJ
,
Kissela
BM
,
Kittner
SJ
,
Lackland
DT
,
Lichtman
JH
,
Lisabeth
LD
,
Makuc
DM
,
Marcus
GM
,
Marelli
A
,
Matchar
DB
,
Moy
CS
,
Mozaffarian
D
,
Mussolino
ME
,
Nichol
G
,
Paynter
NP
,
Soliman
EZ
,
Sorlie
PD
,
Sotoodehnia
N
,
Turan
TN
,
Virani
SS
,
Wong
ND
,
Woo
D
,
Turner
MB
;
American Heart Association Statistics Committee and Stroke Statistics Subcommittee
:
Heart disease and stroke statistics—2012 update: A report from the American Heart Association.
Circulation
2012
;
125
:
e2
220
88.
Steiner
LA
,
Johnston
AJ
,
Czosnyka
M
,
Chatfield
DA
,
Salvador
R
,
Coles
JP
,
Gupta
AK
,
Pickard
JD
,
Menon
DK
:
Direct comparison of cerebrovascular effects of norepinephrine and dopamine in head-injured patients.
Crit Care Med
2004
;
32
:
1049
54
89.
Ogoh
S
,
Sato
K
,
Fisher
JP
,
Seifert
T
,
Overgaard
M
,
Secher
NH
:
The effect of phenylephrine on arterial and venous cerebral blood flow in healthy subjects.
Clin Physiol Funct Imaging
2011
;
31
:
445
51